Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Censo Biotechnologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11167
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays; and custom cell culture services. It also provides training and consultancy services. Censo utilizes stem cell technology to discover and develop new treatments for diseases. The company’s expertise spans in cell printing, 2D cell culture, matrices and 3D culture systems, media and supplement development, cryopreservation technologies and bioreactors among others. Censo is headquartered in Midlothian, Scotland, the UK.

Censo Biotechnologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Censo Biotechnologies Raises USD1.7 Million in Financing 10
Partnerships 11
Censo Biotech Partners with University of Leeds 11
Evotec Enters into Agreement with Censo Biotech 12
Cellectricon Enters into Agreement with Censo Biotech 13
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 14
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 15
Acquisition 16
Roslin Cellab Acquires Roslin Cell Sciences 16
Censo Biotechnologies Ltd – Key Competitors 17
Censo Biotechnologies Ltd – Key Employees 18
Censo Biotechnologies Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Apr 17, 2018: Censo Biotechnologies: Update on iPSC-derived Cortical Neuronal High Content Assay 20
Nov 21, 2017: Censo Biotechnology awarded SMART funding to develop new stem cell technology 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Censo Biotechnologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Censo Biotechnologies Raises USD1.7 Million in Financing 10
Censo Biotech Partners with University of Leeds 11
Evotec Enters into Agreement with Censo Biotech 12
Cellectricon Enters into Agreement with Censo Biotech 13
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 14
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 15
Roslin Cellab Acquires Roslin Cell Sciences 16
Censo Biotechnologies Ltd, Key Competitors 17
Censo Biotechnologies Ltd, Key Employees 18
Censo Biotechnologies Ltd, Subsidiaries 19

List of Figures
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Censo Biotechnologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prime Polymer Co Ltd:企業の戦略的SWOT分析
    Prime Polymer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Trent Limited (TRENT):企業の財務・戦略的SWOT分析
    Trent Limited (TRENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • Yara International ASA:企業の戦略・SWOT・財務分析
    Yara International ASA - Strategy, SWOT and Corporate Finance Report Summary Yara International ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Yingli Green Energy Holding Company Limited (YGE):電力:M&Aディール及び事業提携情報
    Summary Yingli Green Energy Holding Company Limited (Yingli Solar) is a solar panel manufacturer. It designs, assembles, sells, and installs solar PV systems. It covers the entire value chain of solar PV industry ranging from designing to manufacturing of multicrystalline polysilicon ingots, wafers, …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • CAS Medical Systems Inc (CASM)-医療機器分野:企業M&A・提携分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers products such as FORE-SIGHT absolute tissue oximeter, blood pressure measurement technology, vital signs monitors and supplies for neonatal intens …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • KACO new energy GmbH:企業の戦略的SWOT分析
    KACO new energy GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sony Corp (6758):電力:M&Aディール及び事業提携情報
    Summary Sony Corporation (Sony) is a manufacturer of electronic equipment, semiconductors, medical related equipment, instruments, and devices. The company’s products comprises televisions, mobile phones, music systems, cameras, game consoles and software, semiconductors, batteries and other electro …
  • Weihai Guangtai Airport Equipment Co., Ltd.:企業の戦略・SWOT・財務情報
    Weihai Guangtai Airport Equipment Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Weihai Guangtai Airport Equipment Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Scb Life Assurance Public Company Limited
    Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • UniQure NV (QURE):企業の財務・戦略的SWOT分析
    UniQure NV (QURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ithaca Energy Ltd:企業の戦略的SWOT分析
    Ithaca Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Flanders Institute for Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Flanders Institute for Biotechnology (VIB) is a non-profit life sciences research institute that offers pharmaceutical, agricultural, and other industrial research programs. The institute offers research services in areas of cardiovascular medicine, bioinformatics, proteomics and systems bio …
  • Regis Healthcare Ltd:企業の戦略・SWOT・財務情報
    Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Capitol Health Ltd (CAJ):医療機器:M&Aディール及び事業提携情報
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider to the healthcare market.. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆